| 1 |
33144341 | Functional Investigation of Solute Carrier Family 35, Member F2, in Three Cellular Models of the Primate Blood-Brain Barrier. | 2021 Jan |
3 |
| 2 |
33418944 | SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells. | 2021 Jan 6 |
2 |
| 3 |
33831396 | Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cells. | 2021 Jun |
2 |
| 4 |
34815782 | USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2. | 2021 |
3 |
| 5 |
32357518 | YM155-Adapted Cancer Cell Lines Reveal Drug-Induced Heterogeneity and Enable the Identification of Biomarker Candidates for the Acquired Resistance Setting. | 2020 Apr 26 |
1 |
| 6 |
32916603 | Safe scarless cassette-free selection of genome-edited human pluripotent stem cells using temporary drug resistance. | 2020 Dec |
2 |
| 7 |
31157201 | Structure-Activity Relationship Analysis of YM155 for Inducing Selective Cell Death of Human Pluripotent Stem Cells. | 2019 |
1 |
| 8 |
28465296 | Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155. | 2017 May |
2 |
| 9 |
25064833 | The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity. | 2014 Sep |
1 |